Center for Health Innovation and Outcomes Research, Northwell Health, Manhasset, NY, USA.
Cancer Prevention Fellowship Program, Division of Cancer Prevention, National Cancer Institute, Rockville, MD, USA.
JNCI Cancer Spectr. 2021 Mar 22;5(3). doi: 10.1093/jncics/pkab027. eCollection 2021 Jun.
Although it is well documented that adolescents and young adults (AYAs) with cancer have low participation in cancer clinical trials (CCTs), the underlying reasons are not well understood. We used the National Cancer Institute Community Oncology Research Program (NCORP) network to identify barriers and facilitators to AYA CCT enrollment, and strategies to improve enrollment at community-based and minority and/or underserved sites.
We performed one-on-one semistructured qualitative interviews with stakeholders (NCORP site principle investigators, NCORP administrators, physicians involved in enrollment, lead clinical research associates or clinical research nurses, nurse navigators, regulatory research associates, patient advocates) in the AYA CCT enrollment process. NCORP sites that included high and low AYA-enrolling affiliate sites and were diverse in geography and department representation (eg, pediatrics, medical oncology) were invited to participate. All interviews were recorded and transcribed. Themes related to barriers and facilitators and strategies to improve enrollment were identified.
We conducted 43 interviews across 10 NCORP sites. Eleven barriers and 13 facilitators to AYA enrollment were identified. Main barriers included perceived limited trial availability and eligibility, physician gatekeeping, lack of provider and research staff time, and financial constraints. Main facilitators and strategies to improve AYA enrollment included having a patient screening process, physician endorsement of trials, an "AYA champion" on site, and strong communication between medical and pediatric oncology.
Stakeholders identified several opportunities to address barriers contributing to low AYA CCT enrollment at community-based and minority and/or underserved sites. Results of this study will inform development and implementation of targeted interventions to increase AYA CCT enrollment.
尽管有大量文献证明青少年和年轻成人(AYAs)参与癌症临床试验(CCTs)的比例较低,但其中的根本原因仍不清楚。本研究利用美国国家癌症研究所社区肿瘤研究计划(NCORP)网络,旨在确定社区和少数民族/服务欠缺地区的 AYA 参与 CCT 的障碍和促进因素,以及提高参与率的策略。
我们对参与 AYA 参与 CCT 招募过程的利益相关者(NCORP 站点主要研究者、NCORP 管理员、参与招募的医生、主要临床研究助理或临床研究护士、护士导航员、监管研究助理、患者代言人)进行了一对一的半结构化定性访谈。邀请了包括高和低 AYA 招募附属站点的 NCORP 站点参加,这些站点在地理位置和科室代表方面具有多样性(例如儿科、肿瘤内科)。所有访谈均进行了录音和转录。确定了与障碍和促进因素以及提高参与率的策略相关的主题。
我们在 10 个 NCORP 站点进行了 43 次访谈。确定了 11 个阻碍 AYA 入组的因素和 13 个促进因素。主要障碍包括认为试验机会和资格有限、医生把关、缺乏提供者和研究人员时间以及财务限制。促进 AYA 入组的主要因素和策略包括有患者筛选流程、医生对试验的认可、现场的“AYA 支持者”以及医学和儿科肿瘤学之间的良好沟通。
利益相关者确定了一些机会,可以解决导致社区和少数民族/服务欠缺地区 AYA 参与 CCT 率低的障碍。本研究的结果将为制定和实施旨在增加 AYA 参与 CCT 的针对性干预措施提供信息。